NL-OMON45188已完成不适用
Advanced glycation end products in patients with peripheral artery disease or abdominal aortic aneurysms - ARTERY study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age above 18 years old.
- •Written informed consent for study participation.
- •Proven PAD or AAA
- •PAD: patients planned for a bypass surgery or endarterectomy of the lower arteries, and/or:
- •AAA: patients planned for an open repair of the aneurysm.
排除标准
- •Patients not able or willing to sign informed consent.
- •rheumatoid arthritis, systemic lupus erythematosus, Giant Cell Arteritis, retroperitoneal fibrosis, Takayasu arteritis or any other systemic inflammatory disorder.
- •Patients with Ehlers-Danlos syndrom or Marfan syndrom
- •Patients with signs of an inflammatory or mycotic aneurysm (on computed tomographic angiography).
研究者
相似试验
尚未招募
不适用
Advanced Glycation End Products in Patients with Peripheral Arterial Occlusive Disease or Abdominal Aortic AneurysmPatients with an abdominal aortic aneurysm (AAA) or peripheral arterial occlusive disease (PAOD) with and without diabetes mellitus.NL-OMON29072niversity Medical Center Groningen120
已完成
不适用
Advanced Glycation End products in Children with Obesity and Children with Diabetes Mellitus type 1obesitasAdvanced Glycation End products. glycated proteins10018424NL-OMON40284Sint Antonius Ziekenhuis300
已完成
不适用
Accumulation of advanced glycation endproducts in patients with systemic amyloidosis.EiwitvouwziekteProtein folding diseaseAmyloidosisNL-OMON42888Reumatologie en Klinische Immunologie100
招募中
Unknown
The effect of low advanced glycation end product (AGEs) diet on bone health and cardio-metabolic parameters in obese postmenopausal women: a randomized controlled trialE66ObesityDRKS00034643Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences80
进行中（未招募）
不适用
A new non-invasive method to assess cardiovascular risks in type 2 diabetic patients and the correlation to treatment typesType 2 diabetes mellitusNutritional, Metabolic, EndocrineISRCTN50136555Melk General Hospital180